Article
Development of the first low nanomolar Liver Receptor Homolog-1 agonist through structure-guided design
2019-05-17
Abstract excerpt
<h4>ABSTRACT</h4> As a key regulator of metabolism and inflammation, the orphan nuclear hormone receptor, Liver Receptor Homolog-1 (LRH-1), has potential as a therapeutic target for diabetes, nonalcoholic fatty liver disease, and inflammatory bowel diseases. Discovery of LRH-1 modulators has been difficult, in part due to the tendency for synthetic compounds to bind unpredictably within the lipophilic binding poc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e5742c10-2f46-5e8c-a124-b8179ec8614d
- DOI
- 10.1101/639732
